SELZOTAS

(SULFASALAZINE 500/1000mg DELAYED RELEASE ENTERIC COATED TABLET)

Orthopaedic

SELZOTAS

(SULFASALAZINE 500/1000mg DELAYED RELEASE ENTERIC COATED TABLET)

Orthopaedic

Indications

• RHEUMATOID ARTHRITIS
• CROHN’S DISEASE

How it works

SELZOTAS containing Sulfasalazine, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn’s disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth.

Indications

• RHEUMATOID ARTHRITIS
• CROHN’S DISEASE

Dosage

Adults—At first, 500 mg to 1000 milligrams (mg) per day, divided into 2 doses. Your doctor may increase your dose as needed. However, the dose is usually not more than 3000 mg per day

Side Effects

• Aching of joints
• fever
• headache (continuing)
• increased sensitivity of the skin to sunlight
• skin rash or itching
• vomiting

Contraindication

Contraindications to sulfasalazine include patients with hypersensitivity to sulfasalazine, its metabolite, sulfonamides, salicylates, or any component of the formulation, intestinal or urinary obstruction, and porphyria.

Technical information

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Orthopaedic

Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Uncategorized
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.